Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997;104(6-7):649-60.
doi: 10.1007/BF01291883.

Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease

Affiliations

Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease

J Lan et al. J Neural Transm (Vienna). 1997.

Abstract

In this study a chronic cerebral iron-loaded model was established by feeding mice with high iron diet. Data indicated that brain iron concentrations were significantly increased in iron-fed mice compared with those of controls. A significant increase in oxidized glutathione (GSSG), decrease in total glutathione (oxidized and reduced glutathione, GSSG + GSH), and therefore increase in the GSSG/(GSSG + GSH) ratios were observed in iron-loaded mice. Hydroxyl radical (.OH) levels in striatum and brainstem were also significantly increased. Excessive iron alone did not change either dopamine (DA) or lipid peroxidation (LPO) concentrations in striatum. However, a single injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30 mg/kg, i.p.) into the iron-loaded mice caused a great enhancement in all these biochemical abnormalities. These findings suggest that iron does induce oxidative stress, but not severely injury neurons per sc. Excessive iron accumulation in the brain, however, is a potential risk for neuronal damage, which may promote by triggering factor(s). This supports the hypothesis that excessive cerebral iron may contribute to the aetiology of Parkinson's disease (PD).

PubMed Disclaimer

References

    1. J Neurochem. 1980 Nov;35(5):1242-5 - PubMed
    1. Eur J Pharmacol. 1991 Dec 12;208(4):273-86 - PubMed
    1. Acta Neurol Scand Suppl. 1993;146:6-13 - PubMed
    1. J Neurochem. 1987 Jul;49(1):1-8 - PubMed
    1. Nature. 1988 Jul 28;334(6180):345-8 - PubMed

LinkOut - more resources